A biopharmaceutical company, which focuses on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics, including melanocortin-based therapeutics.


Updates from The Motley Fool

Latest updates on Palatin Technologies from Fool.com.


Stock Performance

View Interactive PTN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Palatin Technologies.
Current Price: $0.38
Prev Close: $0.38
Open: $0.39
Bid: $0.37
Ask: $0.38
Day's Range: $0.37 - $0.39
52wk Range: $0.29 - $0.90
Volume: 794,131
Avg Vol 2,752,421
Market Cap: $58M
P/E (ttm): -1.65
EPS (ttm): ($0.23)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Palatin Technologies.
CAPS Rating 3 out of 5
 
118 Outperform
5 Underperform
CAPS All Stars
 
23 Outperform
3 Underperform

How do you think Palatin Technologies will perform against the market?



You pick for Palatin Technologies is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Carl Spana, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Palatin Technologies.

A biopharmaceutical company, which focuses on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics, including melanocortin-based therapeutics.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Drug Makers